Acute Promyelocytic Leukemia in a Woman with Thalassemia Intermedia: Case Report and Review of Literature on Hematological Malignancies in β-Thalassemia Patients.
Claudio PellegrinoGiulia DragonettiPatrizia ChiusoloMonica RossiNicoletta OrlandoLuciana TeofiliPublished in: Hematology reports (2022)
Patients affected by transfusion-dependent β-thalassemia are prone to developing several clinical complications, mostly related to the iron overload. We report the case of a patient affected by transfusion-dependent β-thalassemia (TDT) developing acute promyelocytic leukemia (APL). In our case, the therapeutic management was significantly complicated not only by myocardial dysfunction, but also by the occurrence of the differentiation syndrome following all-trans retinoic acid (ATRA) administration. We carried out a careful revision of the current literature on the occurrence of hematological malignancies in β-thalassemia patients to investigate the major complications so far described. APL occurrence in β-thalassemia patients has been very rarely reported, and our experience suggests that TDT patients suffering pre-existing comorbidities may develop a potentially fatal complication during ATRA therapy.
Keyphrases
- end stage renal disease
- ejection fraction
- newly diagnosed
- prognostic factors
- acute myeloid leukemia
- stem cells
- heart failure
- bone marrow
- mesenchymal stem cells
- systematic review
- total knee arthroplasty
- case report
- liver failure
- sickle cell disease
- risk factors
- left ventricular
- acute respiratory distress syndrome
- mechanical ventilation